BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28363926)

  • 21. The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate.
    Pareek M; Pattison HM
    Br J Gen Pract; 2000 Dec; 50(461):969-71. PubMed ID: 11224968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measles epidemiology and outbreak response immunization in a rural community in Peru.
    Sniadack DH; Moscoso B; Aguilar R; Heath J; Bellini W; Chiu MC
    Bull World Health Organ; 1999; 77(7):545-52. PubMed ID: 10444877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with uptake of measles, mumps, and rubella vaccine (MMR) and use of single antigen vaccines in a contemporary UK cohort: prospective cohort study.
    Pearce A; Law C; Elliman D; Cole TJ; Bedford H;
    BMJ; 2008 Apr; 336(7647):754-7. PubMed ID: 18309964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measles outbreak in Qassim, Saudi Arabia 2007: epidemiology and evaluation of outbreak response.
    Jahan S; Al Saigul AM; Abu Baker MA; Alataya AO; Hamed SA
    J Public Health (Oxf); 2008 Dec; 30(4):384-90. PubMed ID: 18716046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measles immunization of 2-year-olds in a rural southern state.
    Feldman S; Andrew M; Gilbert J; Bracken B; Thompson FE
    JAMA; 1994 May; 271(18):1417-20. PubMed ID: 8176803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress towards measles and rubella elimination in Tuscany, Italy: the role of population seroepidemiological profile.
    Bechini A; Boccalini S; Tiscione E; Pesavento G; Mannelli F; Peruzzi M; Rapi S; Mercurio S; Bonanni P
    Eur J Public Health; 2012 Feb; 22(1):133-9. PubMed ID: 20880991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lessons from a system-wide response to a measles outbreak, Canterbury, February-April 2019.
    Williams D; Dilcher M; Dong H; Lester B; Marshall K; Pink R; Smith D; Wong J
    N Z Med J; 2020 Sep; 133(1522):71-83. PubMed ID: 32994618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The measles/rubella immunisation campaign in Scotland.
    Skinner R; Christie P; Cowden JM
    Health Bull (Edinb); 1996 Jan; 54(1):88-98. PubMed ID: 8820234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An outbreak of measles in an undervaccinated community.
    Gahr P; DeVries AS; Wallace G; Miller C; Kenyon C; Sweet K; Martin K; White K; Bagstad E; Hooker C; Krawczynski G; Boxrud D; Liu G; Stinchfield P; LeBlanc J; Hickman C; Bahta L; Barskey A; Lynfield R
    Pediatrics; 2014 Jul; 134(1):e220-8. PubMed ID: 24913790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outbreak of measles in primary school students with high first dose MMR vaccination coverage.
    Ong G; Rasidah N; Wan S; Cutter J
    Singapore Med J; 2007 Jul; 48(7):656-61. PubMed ID: 17609829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the Auckland 2014 measles outbreak indicates that adolescents and young adults could benefit from catch-up vaccination.
    Reynolds G; Dias C; Thornley S; King R; Morrison A; Matson A; Hoskins R
    N Z Med J; 2015 Sep; 128(1422):53-62. PubMed ID: 26411847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can Flanders resist the measles outbreak? Assessing vaccination coverage in different age groups among Flemish residents.
    Braeckman T; Theeten H; Roelants M; Blaizot S; Hoppenbrouwers K; Maertens K; Van Damme P; Vandermeulen C
    Epidemiol Infect; 2018 Jun; 146(8):1043-1047. PubMed ID: 29716667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sero-epidemiological study in prediction of the risk groups for measles outbreaks in Vojvodina, Serbia.
    Ristić M; Milošević V; Medić S; Djekić Malbaša J; Rajčević S; Boban J; Petrović V
    PLoS One; 2019; 14(5):e0216219. PubMed ID: 31071124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistence of susceptibility to measles in France despite routine immunization: a cohort analysis.
    Chauvin P; Valleron AJ
    Am J Public Health; 1999 Jan; 89(1):79-81. PubMed ID: 9987470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measles in the United Kingdom 1990-2008 and the effectiveness of measles vaccines.
    Jick H; Hagberg KW
    Vaccine; 2010 Jun; 28(29):4588-92. PubMed ID: 20470793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Containing a measles outbreak in Minnesota, 2017: methods and challenges.
    Banerjee E; Griffith J; Kenyon C; Christianson B; Strain A; Martin K; McMahon M; Bagstad E; Laine E; Hardy K; Grilli G; Walters J; Dunn D; Roddy M; Ehresmann K
    Perspect Public Health; 2020 May; 140(3):162-171. PubMed ID: 31480896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MMR vaccine effectiveness in an outbreak that involved day-care and primary schools.
    Barrabeig I; Rovira A; Muñoz P; Batalla J; Rius C; Sánchez JA; Domínguez À
    Vaccine; 2011 Oct; 29(45):8024-31. PubMed ID: 21893145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An ongoing large outbreak of measles in Merseyside, England, January to June 2012.
    Vivancos R; Keenan A; Farmer S; Atkinson J; Coffey E; Dardamissis E; Dillon J; Drew RJ; Fallon M; Huyton R; Jarvis R; Marsh G; Mason R; Shryane T; Stewart A; Ghebrehewet S
    Euro Surveill; 2012 Jul; 17(29):. PubMed ID: 22835470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.